- Home
- CAL vs AURA Comparison
CAL vs AURA Comparison
Compare CAL & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAL
- AURA
- Stock Information
- Founded
- CAL 1878
- AURA 2007
- Country
- CAL United States
- AURA United States
- Employees
- CAL N/A
- AURA N/A
- Industry
- CAL Shoe Manufacturing
- AURA Biotechnology: Pharmaceutical Preparations
- Sector
- CAL Consumer Discretionary
- AURA Health Care
- Exchange
- CAL Nasdaq
- AURA Nasdaq
- Market Cap
- CAL 446.5M
- AURA 396.8M
- IPO Year
- CAL N/A
- AURA 2021
- Fundamental
- Price
- CAL $14.69
- AURA $6.49
- Analyst Decision
- CAL Hold
- AURA Strong Buy
- Analyst Count
- CAL 1
- AURA 6
- Target Price
- CAL $14.00
- AURA $22.33
- AVG Volume (30 Days)
- CAL 871.4K
- AURA 217.8K
- Earning Date
- CAL 05-29-2025
- AURA 08-07-2025
- Dividend Yield
- CAL 1.90%
- AURA N/A
- EPS Growth
- CAL N/A
- AURA N/A
- EPS
- CAL 2.43
- AURA N/A
- Revenue
- CAL $2,677,706,000.00
- AURA N/A
- Revenue This Year
- CAL N/A
- AURA N/A
- Revenue Next Year
- CAL $3.48
- AURA N/A
- P/E Ratio
- CAL $6.08
- AURA N/A
- Revenue Growth
- CAL N/A
- AURA N/A
- 52 Week Low
- CAL $12.09
- AURA $4.35
- 52 Week High
- CAL $44.51
- AURA $12.38
- Technical
- Relative Strength Index (RSI)
- CAL 58.35
- AURA 59.68
- Support Level
- CAL $12.14
- AURA $5.96
- Resistance Level
- CAL $15.02
- AURA $6.68
- Average True Range (ATR)
- CAL 0.67
- AURA 0.36
- MACD
- CAL 0.30
- AURA 0.01
- Stochastic Oscillator
- CAL 88.74
- AURA 97.70
About CAL Caleres Inc.
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.